Anti-PDK2 antibody [EPR1948Y]
Anti-PDK2 항체 [EPR1948Y]
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- 각 태그의 뜻
5
(2 리뷰들)
|
(30 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal PDK2 antibody. Suitable for IHC-P, IP, WB and reacts with Human, Rat, Mouse samples. Cited in 30 publications.
대체 명칭 보기
PDHK2, PDK2, Pyruvate dehydrogenase kinase isoform 2, PDH kinase 2, PDKII
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDK2 antibody [EPR1948Y] (AB68164)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cardiac muscle tissue sections labeling PDK2 with Purified ab68164 at 1/1000 dilution (0.12 µg/mL). Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0). Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDK2 antibody [EPR1948Y] (AB68164)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human bladder carcinoma tissue sections labeling PDK2 with Purified ab68164 at 1/1000 dilution (0.12 µg/mL). Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0). Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IP
Lab
Immunoprecipitation - Anti-PDK2 antibody [EPR1948Y] (AB68164)
Purified ab68164 at 1/20 dilution (0.6µg) immunoprecipitating PDK2 in Rat heart lysate.
Lane 1 (input) : Rat heart lysate 10µg
Lane 2 (+) : ab68164 + Rat heart lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab68164 in Rat heart lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 48 kDa
All lanes:
Immunoprecipitation - Anti-PDK2 antibody [EPR1948Y] (ab68164)
Predicted band size: 106 kDa,46 kDa
false
- WB
Lab
Western blot - Anti-PDK2 antibody [EPR1948Y] (AB68164)
This data was developed using ab227847, the same antibody clone in a different buffer formulation.
Western blot : Rabbit Monoclonal[EPR1948Y] to PDK2 ab227847 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 45 kDa in Wild-type U-87 MG cell lysates with no signal observed at this size in PDK2 knockout U-87 MG cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-PDK2 antibody [EPR1948Y] - BSA and Azide free (<a href='/ko/products/primary-antibodies/pdk2-antibody-epr1948y-bsa-and-azide-free-ab227847'>ab227847</a>) at 1/1000 dilution
Lane 1:
Wild-type U-87 MG at 20 µg
Lane 2:
PDK2 knockout U-87 MG at 20 µg
Lane 3:
SH-SY5Y at 20 µg
Lane 4:
HL-60 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 45 kDa
Observed band size: 46 kDa,36 kDa
false
- WB
Unknown
Western blot - Anti-PDK2 antibody [EPR1948Y] (AB68164)
All lanes:
Western blot - Anti-PDK2 antibody [EPR1948Y] (ab68164) at 1/200 dilution
All lanes:
Human heart lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 46 kDa
false
- WB
Unknown
Western blot - Anti-PDK2 antibody [EPR1948Y] (AB68164)
All lanes:
Western blot - Anti-PDK2 antibody [EPR1948Y] (ab68164) at 1/1000 dilution
Lane 1:
Mouse heart lysate at 20 µg
Lane 2:
Rat heart lysate at 20 µg
Lane 3:
Rat skeletal muscle lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 46 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-PDK2 antibody [EPR1948Y] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDK2 regulates cellular energy metabolism by phosphorylating the E1 component of PDC resulting in lowered acetyl-CoA production. PDK2 often acts as part of a regulatory complex with PDC influencing metabolic flux within the mitochondria. Its activity can alter ATP production and fatty acid synthesis impacting overall cellular function and energy homeostasis. In response to different metabolic needs the availability and activity of PDK2 modulate the balance between carbohydrate utilization and lipid oxidation.
Pathways
PDK2 has an important role in the glucose and lipid metabolic pathways by interacting with PDC. The pathways where PDK2 is active are essential for maintaining energy homeostasis and are sensitive to different physiological conditions. PDK2's regulation of pyruvate oxidation influences the tricarboxylic acid (TCA) cycle affecting key metabolic enzymes such as pyruvate dehydrogenase phosphatase 1 (PDP1) and PDK1. Its activity is often fine-tuned by factors impacting energy needs insulin signaling and nutrient availability.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (30)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Frontiers in immunology 16:1537365 PubMed40018034
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 57:390-401 PubMed39894827
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 24:190 PubMed38750550
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pathogens (Basel, Switzerland) 12: PubMed38003764
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 35:1163-1178.e10 PubMed37327791
2023
Applications
Unspecified application
Species
Unspecified reactive species
Kidney360 4:1080-1094 PubMed37222594
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 14: PubMed36432491
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 69:370-382 PubMed35081724
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Regulatory, integrative and comparative physiology 322:R83-R98 PubMed34851727
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed33672385
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com